trial?

Hi Eric-
I agree that we all need to contribute to finding a cure...ultimately, how we approach our treatment is a very personal one.Regarding herceptin vs. vaccine, is there any data that supports higher efficacy for prevention of recurrence in early stage BC with herceptin vs. prevention fo recurrence in early stage BC with the vaccine?I don't think I've seen any data that supports either as a stronger preventative drug.
I was faced with a similar decision when I was going through treatment.After 8 weeks on Navelbine/Herceptin and my disease progressed, so I had the choice of enrolling in a Phase II clinical trial or switching to Herceptin+Taxol.I chose to participate in the clinical trial(taxol+study drug, NO herceptin).27 weeks later, I was told my disease was stable and taken off the trial.3 weeks after that,we discovered new liver mets & some suspicious lung and sternal lymph nodes stuff.At that point, I went on taxol/herceptin & 12 weeks later declared NED.
Were those 27 weeks on the clinical trial wasted?Do I regret not going directly to herceptin/taxol instead of enrolling in the clinical trial?I don't think so, and my onc believes my exposure to the study drug and now the herceptin are what are keeping my disease at bay-especially since my first attempt at treatment with herceptin resulted in disease progression.
No one knows the answers.Just go with confidence that you are making the best decision possible for you and your with the most education and information you can find.
I hope I have been helpful.Please feel free to contact me directly.Praying for you and your wife, take good care of her.
Keep the faith,
Jessica